SGLT-2 Inhibitors: Proliferating Indications and Perioperative Pitfalls
Author:
Funder
Novartis
Dana-Farber Cancer Institute
Publisher
Elsevier BV
Subject
Anesthesiology and Pain Medicine,Cardiology and Cardiovascular Medicine
Reference28 articles.
1. Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: Cardiovascular and Kidney effects, potential mechanisms, and clinical applications;Heerspink;Circulation,2016
2. Perioperative considerations for the use of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes;Peacock;Anesth Analg,2018
3. The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes;Cherney;Diabetologia,2016
4. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015
5. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Acidosis and aspiration: Popular diabetes medications and the risks they pose in the perioperative period;Journal of Clinical Anesthesia;2024-08
2. Antidiabetic Advancements In Silico: Pioneering Novel Heterocyclic Derivatives through Computational Design;Current Signal Transduction Therapy;2024-07
3. Insilico designing of novel imidazothiadiazole derivatives as SGLT2 inhibitors in emerging potential for Antidiabetic Therapeutics;2023-05-30
4. Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor Therapy: A Case Report;AACN Advanced Critical Care;2023-03-15
5. Detection of Euglycemic Diabetic Ketoacidosis During Thoracic Surgery 75 Hours After Empagliflozin Discontinuation;Cureus;2022-10-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3